pivalde,Iagreetheinfofromthetrialleavesroomforguesswork.ItisinterestingthatbothBIIBandAstraZenica/TakedaaregoingdirectlyafterA-Synintheveryearlystagesofthedisease(Parkinsons),whenA-SynlevelsareapparentlydroppingintheCSF(spinalfluid).Skint, the guesswork is helped at least a bit by the animal study. PBT434 cleared alpha-synuclein from the brain of the animals and ATH for sure knows what did happen in the CSF at the same time in these animals. Perhaps there was first a lot of synuclein in the CFS of the animals after starting PBT434 and gradually less of it. So my guess is that in the phase 1 study there was an increase of alpha-synuclein in the CFS already after 1 week on PBT434 and that is already a sign of "an inhibition" of alpha-synuclein causing harm in the brain. This is still guesswork, however. Brain biopsies would be beneficial.
ThisisstillearlydayswithBIIBrecruitingphase2andAZjuststartingphase1,buttomeitlookslikePBT434hasmorechanceofsuccess,withawiderrangeofeffects,suchasthosebeinginvestigatedbytheFairpark2trialwitharelateddrug.TheyarenotevenreportingA-SynasfarasIcansee.
AllIMOasanonmedicalobserver.
- Forums
- ASX - By Stock
- PBT434 inhibits alpha- synuclein in the brain.
Skint, the guesswork is helped at least a bit by the animal...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $34 | 10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 17196248 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 130790145 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 17196248 | 0.003 |
68 | 89903179 | 0.002 |
29 | 140710133 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 130790145 | 27 |
0.005 | 18848455 | 22 |
0.006 | 22089363 | 18 |
0.007 | 54073650 | 25 |
0.008 | 42418463 | 31 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
ATH (ASX) Chart |